Latest Stories
3 Reasons RVTY is Risky and 1 Stock to Buy Instead
Revvity currently trades at $96.77 per share and has shown little upside over the past six months, posting a middling return of 2.5%. The stock also fell short of the S&P 500’s 13.6% gain during that period.
Bel Fuse (BELFA): Buy, Sell, or Hold Post Q3 Earnings?
Bel Fuse has been on fire lately. In the past six months alone, the company’s stock price has rocketed 75.8%, reaching $143.05 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Avoid UAA and 1 Stock to Buy Instead
Under Armour’s stock price has taken a beating over the past six months, shedding 29% of its value and falling to $4.38 per share. This might have investors contemplating their next move.
3 Reasons PCTY is Risky and 1 Stock to Buy Instead
Over the past six months, Paylocity’s stock price fell to $150.91. Shareholders have lost 14.5% of their capital, which is disappointing considering the S&P 500 has climbed by 13.6%. This might have investors contemplating their next move.
3 Reasons to Avoid IP and 1 Stock to Buy Instead
Over the past six months, International Paper’s shares (currently trading at $38.39) have posted a disappointing 16.8% loss, well below the S&P 500’s 13.6% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons SPXC Has Explosive Upside Potential
SPX Technologies currently trades at $207.38 and has been a dream stock for shareholders. It’s returned 292% since December 2020, more than tripling the S&P 500’s 83.9% gain. The company has also beaten the index over the past six months as its stock price is up 32.9% thanks to its solid quarterly results.
3 Reasons to Sell VSCO and 1 Stock to Buy Instead
What a time it’s been for Victoria's Secret. In the past six months alone, the company’s stock price has increased by a massive 188%, reaching $53.03 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid RGA and 1 Stock to Buy Instead
Reinsurance Group of America currently trades at $201.70 per share and has shown little upside over the past six months, posting a middling return of 3.2%. The stock also fell short of the S&P 500’s 13.6% gain during that period.
Monarch (MCRI): Buy, Sell, or Hold Post Q3 Earnings?
Monarch has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 18.1% to $99.46 per share while the index has gained 13.6%.
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead
The past six months have been a windfall for Jazz Pharmaceuticals’s shareholders. The company’s stock price has jumped 50.6%, hitting $163 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.